PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 100 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,883,000 | +304.1% | 836,789 | +265.9% | 0.00% | +300.0% |
| Q4 2018 | $961,000 | -51.4% | 228,711 | -21.5% | 0.00% | -66.7% |
| Q2 2017 | $1,979,000 | -13.9% | 291,489 | +19.8% | 0.00% | 0.0% |
| Q1 2017 | $2,298,000 | +44.3% | 243,389 | +15.5% | 0.00% | -25.0% |
| Q4 2014 | $1,593,000 | +13.3% | 210,698 | -24.8% | 0.00% | +33.3% |
| Q3 2013 | $1,406,000 | +205.7% | 280,100 | +171.7% | 0.00% | +200.0% |
| Q2 2013 | $460,000 | – | 103,089 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|